M2 Pharma - Therapy Areas

European Commission grants authorisation to ViiV Healthcare's Apretude for prevention of HIV

19 September 2023 - Biopharmaceutical company GSK plc (LSE/NYSE: GSK) announced on Wednesday that ViiV Healthcare, a global specialist HIV company primarily owned by GSK, with Pfizer and Shionogi as s...

Celanese to supply VitalDose drug delivery platform for Population Council's MPT Intravaginal Ring

12 September 2023 - Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, announced on Tuesday that it has partnered with the Population Council to provide its VitalDose ...

Gilead, Tentarix Team to Discover and Develop Novel Therapies to Address Unmet Medical Needs Across Cancer and Inflammation

17 August 2023 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) and Tentarix Biotherapeutics have established three multi-year collaborations leveraging Tentarix's prop...

Henry Schein introduces equipment repair subscription - Henry Schein Thrive Service Plus

9 August 2023 - Health care solutions company Henry Schein Inc (Nasdaq: HSIC) on Wednesday unveiled its latest offering, Henry Schein Thrive Service Plus, as part of the Henry Schein Thrive Rewards pr...

Seres Therapeutics provides business updates and reports Q2 2023 financial results

8 August 2023 - Microbiome therapeutics company Seres Therapeutics (Nasdaq: MCRB) released its Q2 2023 financial results and provided key business updates on Monday.Seres announced the FDA's appr...

Gilead Presents New Biktarvy Data

25 July 2023 - - US-based biopharmaceutical company Gilead Sciences, Inc. (NASDAQ: GILD) has posted results from multiple studies reinforcing Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/teno...